Ozempic pill fails to slow Alzheimer’s disease
Ozempic warning: Experts warn of side effects from weight loss drug Experts are warning of the possible side…
Which Healthcare Giant Is the Better Bet?
Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong…
Max Healthcare endocrinology head tells Amitabh Bachchan how to stay fit: ‘Obesity modern chronic disease ki janani hai’
Obesity is one of the most common health problem that India faces. Around 18 crore Indians are chronic…
UK Sugar Tax Extended to Milkshakes: Rediff Moneynews
UK extends sugar tax to milkshakes to combat obesity. Companies must reduce sugar by 2028 or face the…
Milkshakes and coffees targeted in Government’s sugar tax crackdown | Politics | News
A crackdown on sugary drinks will see the sugar tax extended to include packaged milkshakes and coffees, the…
Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight…
Obesity-related metabolic stress may affect brain health far earlier than expected
For decades, scientists have known that what harms the body often harms the brain. Conditions such as obesity,…
Genetic signals reveal why erectile dysfunction develops and who is most at risk
New genomic evidence unmasks the biological pathways driving erectile dysfunction, linking cardiometabolic disease and addiction traits to ED…
Ultra-Processed Foods Affect Every Major Organ System in Your Body and Rewire Your Biology
Image credits: Ishaq Robin. Three studies published in one of the most respected medical journals paint a vivid…
Anaesthetists forced to cancel procedures because of patients keeping quiet about GLP-1 receptor agonists
A growing trend of patients arriving for surgery without telling doctors they are taking GLP-1 receptor agonists is…
Study compares GLP-1 drug benefits and finds substantial variation in clinical effects
A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes…
Study links obesity severity to escalating cardiometabolic and renal disease burden
Obesity severity is incrementally associated with a broad range of cardiometabolic and renal disease burden, as discovered by researchers at…